Molecular Trojan Horses for treating lysosomal storage diseasesAndrés Felipe Leal, Shunji Tomatsu, Carlos Javier Alméciga-Díaz et al.|Molecular Genetics and Metabolism|2023Cited by 7
Yeast-Produced Human Recombinant Lysosomal β-Hexosaminidase Efficiently Rescues GM2 Ganglioside Accumulation in Tay–Sachs DiseaseOrhan Kerim İnci, Volkan Seyrantepe, Diego A. Súarez et al.|Journal of Personalized Medicine|2025Cited by 1
Iduronate-2-sulfatase interactome: validation by yeast two-hybrid assayEliana Benincore-Flórez, Carolina Cardona-Ramírez, Jorge El‐Azaz et al.|Heliyon|2022Cited by 1
Intracerebroventricular Administration of Yeast-Produced Human Recombinant Lysosomal β-Hexosaminidase Partially Corrects GM2 Ganglioside Accumulation in the Tay-Sachs Mouse ModelCarlos Javier Alméciga-Díaz, Angela Johana Espejo-Mojica, Volkan Seyrantepe et al.|İYTE (İZMİR YÜKSEK TEKNOLOJİ ENSTİTÜSÜ)|2025Cited by 0
Treatment with recombinant human lysosomal β-hexosaminidase reduces GM2 accumulation in Tay-Sachs disease cellsOrhan Kerim İnci, Volkan Seyrantepe, Diego A. Súarez et al.|Molecular Genetics and Metabolism|2024Cited by 0